Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Texas Quarterly Meeting Updates

Various topics included topical analgesics, network performance, treatment guidelines, dispute resolution, and legislative priorities.
Read More →
October 19, 2026

FDA Seeks Input to Support Ibogaine Research

To support early clinical trials for the psychedelic, the FDA is asking for information on study design, dosing, safety considerations, and more.
Read More →
October 19, 2026

NCCI Publishes New State of the Line Report

Premium decreased 0.2% in 2025, staying around $41.6 billion, while frequency decreased 2%.
Read More →
October 19, 2026

California Summarizes Key Bills from 2026

AI regulations for litigation and workplace surveillance, workplace safety standards for outdoor pollution, and much more.
Read More →
October 12, 2026

Colorado Updates Utilization Standards and Fee Schedule Rules

The rule updates impact several areas of workers’ comp, ranging from pharmacy reimbursement, DME, telemedicine, and much more.
Read More →
October 12, 2026

Tennessee Medical Advisory Committee Meeting Updates

Topics included ODG updates, rulemaking activity, AMA Guides, mental health claim trends, and utilization review enforcement.
Read More →
October 12, 2026

Texas Publishes 2026 Network Report Card

The report analyzed 22 networks with a total of 219,941 network claims and 216,371 non-network claims, covering injuries from June 2023 and May 2025.
Read More →
October 5, 2026

IAIABC’s 112th Convention: Recap

Key conversations focused on access to care, emerging technologies, GLP-1s, and topical analgesics.
Read More →
October 5, 2026

California Establishes Guardrails for AI Use in Legal and Dispute Resolution Proceedings

Among many rules, attorneys may not delegate the practice of law to generative AI and must protect confidential information.
Read More →
October 5, 2026

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Presumption Expansions Throughout the Country

Several states continue to update presumptions for cancer, PTSD, and other conditions.
Read More

States Continue to Push for Psychedelic-Assisted Therapy Programs

Connecticut, Georgia, and Oklahoma enacted laws to enable certain programs, while a Louisiana bill awaits gubernatorial decisions.
Read More

What Is Marijuana’s Role in Pain Management?

The recent rescheduling of marijuana could be a boon to clinical research on pain management. What is marijuana’s potential role in treating pain?
Read More

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
Read More

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.
Read More
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle